Both in Pharmaceuticals
Bolt Biotherapeutics vs Citius Pharmaceuticals
Over the past year BOLT returned +11.8% and CTXR returned −63.0%; their daily moves had a correlation of 0.09.
BOLT +11.8% CTXR −63.0%Growth of $1, one year, split-adjusted
| Metric | BOLT | CTXR |
|---|---|---|
| Price | $6.24 | $0.5620 |
| Market cap | $14.7M | $15.4M |
| Today | −5.31% | +7.44% |
| 1 month | +80.9% | +5.7% |
| 6 months | +23.3% | −20.9% |
| Year to date | +14.1% | −27.7% |
| 1 year | +8.9% | −64.2% |
| Revenue growth (YoY) | −99.7% | — |
| Gross margin | 100.0% | 67.1% |
| Net margin | −154400.0% | −593.3% |
| P/E (TTM) | — | — |
| Price / sales | 3.1× | 2.2× |
| Net cash | $17.6M | $10.6M |
| Dividend yield | — | — |
| Volatility (60d) | 112.1% | 96.5% |
| Short % of float | 1.1% | 21.9% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).